FOLH1 and neoplasm: Tumor uptake of the control ligand (0.46 ± 0.2% ID/g) was significantly lower (1/27th) compared with the N064 ligand (p<0.001), demonstrating the necessity of an intact PSMA-binding motif for PSMA binding.